Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity.

Yan, Shu; Xue, Shuyu; Wang, Tiantian; Gao, Ruihang; Zeng, Hanqiao; Wang, Qianmeng; Jia, Xiaojing

Yan, Shu; Xue, Shuyu; Wang, Tiantian; Gao, Ruihang; Zeng, Hanqiao; Wang, Qianmeng; Jia, Xiaojing.

Afiliação

Yan S; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Xue S; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Wang T; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Gao R; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Zeng H; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Wang Q; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Jia X; Department of Tumor Radiotherapy, The Second Hospital of Jilin University, Changchun, China.

Front Oncol ; 13: 1086214, 2023.

Article em En | MEDLINE | ID: mdl-37637045

Palavras-chave

nintedanib; non-small cell lung cancer; radiation therapy; radiation-induced lung toxicity; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google